Solid Biosciences (SLDB) Insider Trading & Ownership $5.63 +0.01 (+0.20%) As of 01:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Solid Biosciences (NASDAQ:SLDB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$9.93KNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$156.30K Get SLDB Insider Trade Alerts Want to know when executives and insiders are buying or selling Solid Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLDB Insider Buying and Selling by Quarter Solid Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2025Clare KahnDirectorBuy1,860$5.34$9,932.40 1/28/2025Ilan GanotDirectorSell144$3.11$447.84 1/10/2025Kevin TanCFOSell4,073$3.89$15,843.97 1/6/2025Ilan GanotDirectorSell1,056$4.31$4,551.36 12/3/2024Alexander CumboCEOSell11,114$5.60$62,238.40 12/3/2024David T HowtonCOOSell5,072$5.60$28,403.20 12/3/2024Jessie HanrahanInsiderSell4,610$5.60$25,816.00 10/21/2024Gabriel BrooksInsiderSell2,923$6.50$18,999.50 (Data available from 1/1/2013 forward) SLDB Insider Trading Activity - Frequently Asked Questions Who is on Solid Biosciences' Insider Roster? The list of insiders at Solid Biosciences includes Alexander Cumbo, Carl Ashley Morris, Clare Kahn, David T Howton, Gabriel Brooks, Ilan Ganot, Jessie Hanrahan, Kevin Tan, Paul Herzich, and Perceptive Advisors Llc. Learn more on insiders at SLDB. What percentage of Solid Biosciences stock is owned by insiders? 1.90% of Solid Biosciences stock is owned by insiders. Learn more on SLDB's insider holdings. Which Solid Biosciences insiders have been buying company stock? The following insiders have purchased SLDB shares in the last 24 months: Clare Kahn ($18,369.40), and Perceptive Advisors Llc ($18,861,242.89). How much insider buying is happening at Solid Biosciences? Insiders have purchased a total of 3,413,673 SLDB shares in the last 24 months for a total of $18,879,612.29 bought. Which Solid Biosciences insiders have been selling company stock? The following insiders have sold SLDB shares in the last 24 months: Alexander Cumbo ($94,805.29), David T Howton ($43,323.46), Gabriel Brooks ($18,999.50), Ilan Ganot ($16,934.87), Jessie Hanrahan ($39,379.62), Kevin Tan ($48,110.97), and Paul Herzich ($8,221.36). How much insider selling is happening at Solid Biosciences? Insiders have sold a total of 59,641 Solid Biosciences shares in the last 24 months for a total of $269,775.07 sold. Solid Biosciences Key ExecutivesMr. Ian F. Smith A.C.A. (Age 58)C.P.A., Executive Chair Compensation: $75kMr. Alexander G. Cumbo (Age 53)President, CEO & Director Compensation: $918.55kMr. Ilan Ganot (Age 50)Co-founder, Strategic Advisor to the CEO & Director Compensation: $847.87kMr. Kevin Tan C.F.A. (Age 46)CFO & Treasurer Compensation: $607.18kMr. David Tyronne Howton Jr. (Age 52)J.D., COO, General Counsel & Secretary Compensation: $648.88kMs. Annie GanotCo-Founder & Head of Patient AdvocacyMr. Paul Herzich (Age 46)Chief Technology Officer Dr. Jennifer Marlowe Ph.D. (Age 47)Chief Scientific Officer Ms. Allison Bogosian J.D.Senior Vice President of Human ResourcesDr. Jessie Hanrahan Ph.D. (Age 48)Chief Regulatory Officer More Insider Trading Tools from MarketBeat Related Companies Cidara Therapeutics Insider Buying Dyne Therapeutics Insider Buying Apogee Therapeutics Insider Buying Immunocore Insider Buying Beam Therapeutics Insider Buying Twist Bioscience Insider Buying Travere Therapeutics Insider Buying Aurinia Pharmaceuticals Insider Buying WAVE Life Sciences Insider Buying Edgewise Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:SLDB) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access